Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Marcus & Millichap
MMI
$1.16B
| $15.4M | ﹤0.01% |
403,560
+18,785
| +5% | +$736K |
|
1827
Myriad Genetics
MYGN
$289M
| $15.4M | ﹤0.01% |
1,125,535
+42,233
| +4% | +$779K |
|
1828
National Bank Holdings
NBHC
$1.92B
| $15.4M | ﹤0.01% |
357,049
+1,562
| +0.4% | +$70.7K |
|
1829
Recursion Pharmaceuticals
RXRX
$1.69B
| $15.4M | ﹤0.01% |
2,274,003
+333,323
| +17% | +$2.24M |
|
1830
Columbus McKinnon
CMCO
$580M
| $15.4M | ﹤0.01% |
412,575
+21,830
| +6% | +$792K |
|
1831
Xerox
XRX
$411M
| $15.3M | ﹤0.01% |
1,812,102
+92,495
| +5% | +$853K |
|
1832
Pediatrix Medical
MD
$2.16B
| $15.2M | ﹤0.01% |
1,158,240
-209,105
| -15% | -$2.89M |
|
1833
Brookdale Senior Living
BKD
$3.43B
| $15.2M | ﹤0.01% |
3,017,897
+64,814
| +2% | +$371K |
|
1834
Orion
OEC
$385M
| $15.2M | ﹤0.01% |
960,349
+85,074
| +10% | +$1.44M |
|
1835
AvePoint
AVPT
$2.83B
| $15.2M | ﹤0.01% |
918,345
+20,761
| +2% | +$315K |
|
1836
Scansource
SCSC
$1.16B
| $15.1M | ﹤0.01% |
318,954
-105,480
| -25% | -$5.16M |
|
|
AKRO
1837
DELISTED
Akero Therapeutics
AKRO
| $15M | ﹤0.01% |
540,692
+8,096
| +2% | +$245K |
|
|
HAPN
1838
Happen Inc
HAPN
$2.36B
| $15M | ﹤0.01% |
924,843
+23,486
| +3% | +$346K |
|
1839
Par Pacific Holdings
PARR
$4.16B
| $14.9M | ﹤0.01% |
909,220
+167,594
| +23% | +$2.83M |
|
1840
BioCryst Pharmaceuticals
BCRX
$2.24B
| $14.9M | ﹤0.01% |
1,979,992
+91,998
| +5% | +$698K |
|
1841
TriMas Corp
TRS
$1.45B
| $14.9M | ﹤0.01% |
605,502
+22,656
| +4% | +$594K |
|
1842
Astrana Health
ASTH
$1.78B
| $14.9M | ﹤0.01% |
471,329
+23,533
| +5% | +$1.12M |
|
1843
Trupanion
TRUP
$1.09B
| $14.8M | ﹤0.01% |
306,752
+6,338
| +2% | +$325K |
|
|
DVAX
1844
DELISTED
Dynavax Technologies
DVAX
| $14.8M | ﹤0.01% |
1,155,080
+32,347
| +3% | +$391K |
|
1845
Iovance Biotherapeutics
IOVA
$1.93B
| $14.7M | ﹤0.01% |
1,989,340
+76,196
| +4% | +$706K |
|
1846
CVR Energy
CVI
$3.31B
| $14.7M | ﹤0.01% |
783,079
+143,941
| +23% | +$2.91M |
|
1847
Enovix
ENVX
$921M
| $14.7M | ﹤0.01% |
1,540,960
+136,329
| +10% | +$1.2M |
|
1848
Janux Therapeutics
JANX
$934M
| $14.6M | ﹤0.01% |
273,135
+38,944
| +17% | +$2.06M |
|
1849
Tecnoglass Holdings Inc.
TGLS
$2.07B
| $14.6M | ﹤0.01% |
184,313
+913
| +0.5% | +$69.5K |
|
1850
MannKind Corp
MNKD
$1.17B
| $14.6M | ﹤0.01% |
2,270,106
+45,277
| +2% | +$304K |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.